Liraglutide, a once-daily human GLP-1 analogue, reduces systolic blood pressure within 2 weeks in patients with type 2 diabetes
Fonseca, V., Falahati, A., Zychma, M., Madsbad, S., Plutzky, J.Volume:
33
Year:
2009
Language:
english
Journal:
Canadian Journal of Diabetes
DOI:
10.1016/S1499-2671(09)33184-6
File:
PDF, 450 KB
english, 2009